Amundi increased its position in Arcosa, Inc. (NYSE:ACA – Free Report) by 191.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,000 shares of the company’s stock after buying an additional 16,412 shares during the quarter. Amundi’s holdings in Arcosa were worth $2,375,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of ACA. Proficio Capital Partners LLC purchased a new position in Arcosa in the 4th quarter worth approximately $30,000. GAMMA Investing LLC increased its stake in Arcosa by 80.9% in the 4th quarter. GAMMA Investing LLC now owns 331 shares of the company’s stock worth $32,000 after purchasing an additional 148 shares during the period. Point72 DIFC Ltd purchased a new position in Arcosa in the 3rd quarter worth approximately $37,000. Blue Trust Inc. increased its stake in Arcosa by 16.4% in the 4th quarter. Blue Trust Inc. now owns 1,240 shares of the company’s stock worth $118,000 after purchasing an additional 175 shares during the period. Finally, KBC Group NV increased its stake in Arcosa by 20.5% in the 3rd quarter. KBC Group NV now owns 1,424 shares of the company’s stock worth $135,000 after purchasing an additional 242 shares during the period. Institutional investors own 90.66% of the company’s stock.
Arcosa Price Performance
ACA opened at $80.84 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 2.77 and a current ratio of 3.61. Arcosa, Inc. has a 52-week low of $72.75 and a 52-week high of $113.43. The stock has a market capitalization of $3.94 billion, a PE ratio of 30.74 and a beta of 0.81. The stock’s 50 day moving average price is $94.30 and its 200-day moving average price is $96.57.
Arcosa Announces Dividend
Analyst Upgrades and Downgrades
Separately, Oppenheimer lifted their price target on Arcosa from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th.
Check Out Our Latest Stock Analysis on ACA
About Arcosa
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
Further Reading
- Five stocks we like better than Arcosa
- How to Use the MarketBeat Excel Dividend Calculator
- How to Build the Ultimate Everything ETF Portfolio
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is the NASDAQ Stock Exchange?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.